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Abstract 
Microbial infections have a long history of causing serious illnesses for human and animals. 
The presence of harmful bacteria, especially on the surface of the objects and equipment in 
hospitals, causes many mortalities for ill patients and is a major global challenge.  
The inappropriate usage of antibiotics has lead to antimicrobial resistance development in 
bacteria. The global concern about antimicrobial resistance has triggered the development of 
new and more effective antimicrobial agents. A promising method is the use of novel 
nanomaterials against bacteria in a rapid way so that these bacteria may not be able to develop 
resistance. The nanoparticles (NPs) possess enhanced physicochemical properties compared 
with their bulk counterparts owing to a high surface to volume ratio. The metal and metal oxide 
nanoparticles (NPs) such as Ag, Cu and TiO2 NPs have proven to be effective in killing bacteria 
through various mechanisms such as ion originating from the dissolution of NPs and reactive 
oxygen species (ROS) generated from the photocatalytic process. This research project is 
focused on synthesizing of effective antimicrobial nanocomposites/nanomaterials with novel 
characteristics such as rapidness, multi-mode mechanisms and induction in the visible light 
range. 
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1.1 Background 
The antibiotics have been used to combat bacteria since the 1940s (with the introduction of 
Penicillin) and lead to dramatic reduction of the mortality. It introduced an ambitious hope in 
human history that antibiotics can be expected to eliminate all infectious bacteria. However, 
this hope did not last long as the battle between antibiotics and bacteria became more 
complicated as bacteria use different mechanisms to resist antibiotics.   
The main motivation to produce effective antibiotics is a relatively high number of infections 
caused by antimicrobial-resistant bacteria. The research survey from world health organization 
(WHO) has shown that only in the United States, an estimated number of two million people 
annually is reported to be infected with antimicrobial-resistant bacteria and 23,000 of these 
people die from infections [1]. The Clostridium (C.) difficile bacteria alone in United State 
infects 250,000 people annually and 14,000 of these infected people do not survive from 
infections eventually. The healthcare-associated infections (HCAIs), mainly caused by 
antimicrobial-resistant bacteria, would require the patient with a prolonged hospital stay and 
this brings additional burden to the health system. The HCAIs cause an estimated annual 
financial loss of approximately 7 billion British Pounds in Europe [2]. The culprit in these cases 
is bacterial resistance to the antibiotics. The overuse and/or inappropriate usage of antibiotic 
agents leads to the development of antimicrobial resistant bacteria. Staphylococcus (S.) aureus 
is a common pathogen in hospital environments and is one of several bacterial strains resistant 
to antibiotics and responsible for nosocomial infections [3]. 
The bacteria become resistant to antimicrobial agents by several mechanisms such as: blocking 
entry of the drug into the cell, inactivation of the drug by enzymes, alteration of the drug target 
site, efflux of the drug from the cell or alteration of metabolic pathways of the host. For 
example, natural antimicrobics agents such as penicillins and cephalosporins are mainly 
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inactivated by the enzymatic destruction. However, synthetic antimicrobial agents such as 
fluoroquinolones are less likely to be affected by the enzyme inactivation mechanism [3].  
1.2 Bacteria structure and properties 
The structure and properties of bacteria play a significant role in developing resistance against 
drugs. Bacteria are normally a single cell. The size of bacterial cells is very small, typically less 
than 2 μm in diameter. The bacteria have different cell shapes including spherical, rod-like and 
spiral shapes [3]. The major parts of a bacterium are flagellum, cytoplasm, ribosomes, plasma 
membrane, DNA, capsule, pilus and cell wall. The simplified sketch of a bacterium is shown 
in the following Figure 1 [4]. 
 
Figure 1 Bacterial cell, ca: capsule, cm: cytoplasmic membrane, cp: cytoplasm, cw: cell wall, 
f: flagellum, gly: glycogen, li: lipid droplets, n: nuclear material or bacterial chromosome, phb: 
poly (b-hy-droxybutyric acid), pi: pili or pilus, pl: plasm d, po: polyphosphate, rb: ribosomes, 
s: sulphur granules [4]. 
The architectural structure, thickness and chemical compositions of each layer of the cell wall 
play an important role in the interaction between bacteria and antimicrobial surface agents. In 
1884 Hans Christian Gram devised a method for differentiating bacteria cell walls based on 
their retention of violet crystal dye. The bacteria that retain the violet dye are called 
Gram-positive. The Gram-negative bacteria do not retain the violet dye and change the colour 
to red. It is also discovered that a relationship exists between the thickness of the cell wall layer 
(20 to 50 nm) in Gram-positive bacteria and the extent of retention of violet dye. The common 
antimicrobial-resistance bacteria which have been studied extensively are Escherichia (E.) coli 
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and Pseudomonas (P.) aeruginosa as Gram-negative bacteria and S. aureus and 
Enterococcus (E.) faecalis as Gram-positive bacteria. The bacteria cell wall structure for 
Gram-positive and Gram-negative bacteria is shown in Figure 2. 
 
Figure 2 Bacterial cell wall structure, a: Gram-positive, b: Gram-negative [5] 
The cell wall in bacteria has an essential role in controlling the osmotic pressure of the 
cytoplasm, providing a shape to the cell and protect the cell internals from damages. The cell 
wall in Gram-positive bacteria consists of a thick layer of peptidoglycan polymers with a single 
cytoplasmic membrane. However, the cell wall in Gram-negative bacteria is more complex. It 
consists of an outer membrane, two cell membranes, a plasma membrane and a thin layer of 
peptidoglycan [6, 7]. The difference in bacterial cell wall between Gram-positive and Gram-
negative bacteria has an impact on the effectiveness of nanomaterials-based antimicrobial 
agents. The Gram-negative bacteria are inherently resistant to most antibiotics and biocides 
(e.g. detergents, heavy metals) due to their outer layer which forms a barrier to inhibit the entry 
of biocides into the bacteria. The major factor in selective toxicity of antibiotics is the 
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lipopolysaccharide (LPS) layer in the outer layer of Gram-negative bacteria. The LPS layer also 
contains porins protein that forms a channel across the LPS layer in order to uptake nutrients 
required for bacterial cell metabolism. The porins allow the passage of nucleotides, 
disaccharides and amino acids into Gram-negative bacteria. However, drugs with a large size 
and lipophilic properties, for example an affinity for lipids, could not enter into Gram-negative 
bacteria easily [3]. The antibiotics that have been developed in the past decades are more 
effective in Gram-positive bacteria but very poor for Gram-negative bacteria, which increases 
the demands for new antibiotics and novel antimicrobial agents. 
1.3 Fighting back against antimicrobial resistant bacteria 
Several core strategies are in place in order to fight against antimicrobial resistance. These 
strategies include preventing infections, preventing the spread of resistance, tracking/reducing 
antibiotic prescriptions and developing new drugs and diagnostics tests. 
Preventing infections and the spread of resistance will reduce the need for an antibiotic. As the 
main cause of antibiotic resistance is the overuse of antibiotics, a reduction in usage of 
antibiotics will slow down the pace of antimicrobial resistance. New antibiotics are 
continuously developed as the antibiotic resistance occurs as part of a natural evolution process. 
Ceftaroline developed in 2010 is an example of a new antibiotic to battle against S. aureus and 
Streptococcus infections [8, 9]. However, production of new antibiotics is a time consuming 
and costly process, therefore, other strategies should be employed to prevent the spread and 
eliminating antimicrobial-resistant bacteria. 
The most common physical methods for eliminating bacteria are heat, low temperature, 
desiccation, osmotic pressure and radiation. The sterilization method is a common method to 
eliminate the most persistent bacteria from an object, regardless of different types and different 
growth phases [3]. It could be applied in dry and moist (steam) forms. The advantages of 
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thermal sterilization are availability, ease of control and economic cost. The main mechanism 
of action is denaturation, destroying the enzymes in bacteria. The mechanism for the dry method 
is oxidation of chemical bonds, while the moist method is based on breaking the hydrogen 
bonds of cell proteins by water. The typical conditions for sterilization by heat requires a 
temperature of 121 °C for 15 minutes. At a low temperature, most microorganisms stop 
reproduction. Therefore, the main mechanism for a low temperature is to reduce the growth rate 
of the microorganisms. However, most bacteria can still grow at a much lower rate even at a 
low temperature. The desiccation method removes water from bacteria which is crucial for 
bacterial growth and reproduction. However, bacteria are viable again and resume growth and 
reproduction when water is present. The osmotic method has a similar mechanism as 
desiccation to dewater from bacteria. A high concentration of salts is applied to bacteria, and 
the osmotic pressure drives water from bacteria cells to the salt solution, and bacteria become 
non-viable after losing water [3]. The radiation method in ionizing and non-ionizing forms can 
eliminate bacteria. The wavelength, intensity and treatment duration are important factors for 
this antimicrobial method by radiation. X-ray and gamma rays are examples of ionizing 
radiation. They have a short wavelength with very high energy which can penetrate through the 
bacteria to damage them. The ionizing radiation causes ionization of water molecules to form 
free radicals which are lethal to bacteria due to breaking the DNA strands in bacteria. The 
ultraviolet (UV) light as nonionizing radiation has a higher wavelength with lower energy. The 
mechanism of action for UV light is based on damaging the DNA in the bacteria, which leads 
to binding between thymines in the DNA chains and then disrupts DNA replication [3]. All 
these physical methods have their own limitations. For example, the heat method cannot be 
applied to all surfaces such as hospital walls and doors. The ionizing light like gamma rays uses 
very high energy which can bring damage to most objects. The UV lights have limited 
penetration into objects due to a much lower energy supply.  
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Chemical agents such as phenol and phenolic agents, biguanides, halogens, alcohols and 
aldehydes have proven to be effective in controlling the bacterial growth. However, a single 
chemical agent cannot be used for all types of microbes. The liquid (aqueous) and gaseous 
chemical agents are frequently used for disinfection of surfaces from harmful bacteria. The 
glutaraldehyde solution (C5H8O2) and ethylene oxide (C2H4O) gas are examples of common 
chemical agents widely used to sterilize the medical devices. The phenol and phenolic 
compounds such as biphenols (e.g. Triclosan and Hexachlorophene), oranges (e.g. carvacrol 
and limonene) and O-phenylphenol have antimicrobial properties, normally at a concentration 
greater than 1 % v/v. The phenolic compounds are especially effective against Gram-positive 
bacteria, for example, Hexachlorophene is often used to eliminate the growth of Gram-positive 
staphylococci and streptococci. The antimicrobial mechanism of phenolic compounds depends 
on the chemical structure of the compounds, especially the substitution position of the benzene 
ring and the saturated chain length. Inhibition of the cellular fatty acids enzymes by 
compromising the integrity of the plasma membrane in the bacterial cell wall has been reported 
as the main antimicrobial mechanism of action for the phenolic compounds [10]. The phenolic 
compounds have several advantages including stability and persistence for a long period of time 
and activity in the presence of other organic materials. The main disadvantages include irritation 
of skin and odour [3].  The biguanides agents such as chlorhexidine and alexidine have been 
reported to be effective against Gram-positive bacteria. The antimicrobial mechanism of 
biguanides is mainly based on the alteration of the bacterial cell wall membrane [11-13]. The 
halogens such as iodine (I2), chlorine (Cl2) are strong antimicrobial agents both as pure or 
constituents of other compounds.  Povidone-iodine, calcium hypochlorite (Ca(OCl)2) and 
sodium hypochlorite (NaOCl)) and chloramine (NH2Cl) are several examples of antimicrobial 
halogens compounds. The antimicrobial mechanism of action is based on impairing protein 
synthesis and alteration of cell membrane via binding with amino acids and unsaturated fatty 
acids of bacteria [14-16].   
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Alcohols such as ethanol (C2H5OH) and isopropanol (C2H8O) are very effective antimicrobial 
agents. The alcohols normally eliminate bacteria by disrupting the bacterial membrane, 
denaturising the protein and dissolving the lipids within bacteria. However, pure alcohol is not 
effectively antimicrobial as denaturation requires water, therefore an aqueous solution with a 
concentration of 70 % is normally used in surface disinfection. Aldehydes are another group of 
chemical agents with strong antimicrobial properties. The antimicrobial mechanism is based on 
the formation of covalent cross-links with functional groups on proteins leading to inactivation 
of proteins. Formaldehyde (CH2O) and glutaraldehyde (C5H8O2) are two commonly used 
aldehydes in disinfection of hospital instruments [17, 18]. These chemical methods for 
eliminating bacteria also have limitations. For example, they could cause significant damage to 
the main material of the object, therefore their use is limited. 
1.4 Aim and objectives  
The aim of this research project is to develop effective nanocomposites/nanomaterials for 
antimicrobial purposes. The Ag and TiO2 NPs have been evaluated for antimicrobial properties 
with promising efficacy. The ZnO NP (especially in visible light range) is the least tested 
nanomaterial for antimicrobial application and has a great potential due to high photocatalytic 
characteristics. The main objectives of this research project are:  
 Evaluation of antimicrobial efficacy for a surface coated with a nanostructure 
manufactured by magnetron sputtering. 
 Synthesis of a novel nanomaterial by doping zinc oxide nanoparticles in the visible light 
range for its application as an antimicrobial agent.  
1.5 Thesis structure 
The thesis is prepared in a publication format. In the first chapter, introduction and some 
backgrounds are described. The second chapter includes a literature review related to the 
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research topic. The third chapter presents the antimicrobial coating surfaces paper submitted 
for publication in the Journal of Surface Engineering. The fourth chapter covers antimicrobial 
zinc oxide (single and doped) nanoparticles. In the end, the conclusion is presented to 
summarise the finding on research conducted as part of this degree of Master of Philosophy - 
chemical engineering. 
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Chapter 2 :        Literature review 
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2.1 Antimicrobial coating surfaces 
In hospitals, bacteria can survive on different surfaces such as beds, doorknobs, surgical 
equipment and medical implants, despite widespread use of terminal cleaning such as 
sterilization, wiping with ethanol etc. The most common material which is used in making the 
surfaces for hospital setup surfaces is stainless steel (SS) due to its good corrosion resistance 
and high hardness, as well as low cost and ease of cleaning. However, SS is not antimicrobial.  
The bacteria could form biofilm when they attach and grow on a surface. The infections caused 
by biofilm are especially important for the indwelling devices. The biofilms are normally 
resistant to antibiotics and the host immune system as they delay the penetration or diffusion of 
antimicrobial agents [19]. The presence of biofilms on SS in hospital settings is extremely 
threatening due to the presence of patients with weak or compromised immune systems.  
Several studies have shown the difficulties of removing bacterial biofilms through cleaning by 
disinfectants [20]. 
The biofilm is formed by a polymer-shaped matrix constituted of polysaccharide, protein and 
DNA which are self-produced by bacteria. The bacteria then use the biofilm as a physical barrier 
against antimicrobial agents for growth and colonization, therefore the biofilm acts as a 
protective layer for bacteria.  
The biofilm formation has been investigated extensively so that antimicrobial surfaces can be 
prepared to prevent biofilm formation. Surface contamination often starts with bacterial 
adhesion to the surface. The bacteria cannot colonise on the surface if they cannot attach to the 
surface. Bacteria adhere to the surface via different mechanisms, involving complex chemical 
interactions that lead to biofilm formation. Four stages of formation of the biofilms are 
attachment to a surface, sessile growth, colonization and dispersion, as shown in the following 
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schematic [21].  
 
Figure 1 Biofilm formation stages: attachment to a surface, sessile growth, colonization and 
dispersion [21] 
Adhesion of a bacterial cell to the surface is initiated by interactions of the cell with the surface 
and these interactions are influenced by several forces such as electrostatic and Van der Waals 
forces. The hydrophobicity of the surface and the bacteria cell, for example, 
Staphylococcus (S.) aureus bacteria [22], plays a crucial role in the initial adhesion of the 
bacteria to the surface. The hydrophobicity of the surfaces could be manipulated by synthesis 
methods.  
2.1.1 Antimicrobial surfaces 
The antimicrobial surfaces could be categorized into two main groups: (1) antifouling or 
bacterial repellent surfaces, i.e. preventing bacterial attachment, and (2) bactericidal surfaces, 
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i.e. releasing antimicrobial agents upon contact with bacteria [23]. The following table from 
Davide Campoccia et al. [24] presents important factors for bacterial adhesion to a surface in 
the aqueous phase. 
Table 1 Variables affecting bacterial adhesion to a surface (David Campoccia et al. [24]) 
Surface morphometry macroporosity, microporosity, micro-roughness and nano-
roughness 
Physico-chemical properties surface energy, hydrophilicity/superhydrophylicity, 
hydrophobicity/superhydrophobicity, hydrophobic 
functional groups, polar functional groups, charged 
functional groups, functional groups with specific 
activities, the degree of hydration 
Environmental conditions electrolytes, pH, temperature, host proteins/host, adhesins, 
shear rate/fluid viscosity, fluid flow rate 
Pathogen Gram-positive/Gram-negative, genus/species, bacterial 
shape, surface energy, strain type and specific set of 
expressed adhesins 
 
The bacteria-repellent surfaces are normally realized by surface chemistry modification, for 
example, surface polymerisation. Some examples of polymers for surface coating are 
polyethylene, polypropylene, and polyethylene glycol. The challenge of the surface 
polymerisation method is to control the molecular weight of the coated polymers [23]. Tiller et 
al. [25] synthesized poly(4-vinyl-N-alkylpyridinium bromide) on a glass substrate for the 
antimicrobial application. They reported a 94 % reduction of S. aureus using this synthesised 
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polymeric surface. In another study [26], the interaction between polymers and the 
phospholipid membrane of the bacterial cells was evaluated using poly(2-methyl-1,3-
oxazoline)s (PMOX) with a N,N-dimethyldodecylammonium (DDA) end group and methyl, 
decyl, hexadecyl groups. Hume et al. [27] investigated the efficacy of covalently bound 
furanones to polymers against Staphylococcus (S.) epidermidis. The efficacy of furanone-
coated catheters produced by co-polymerisation with styrene and plasma-1-ethyl-3-
(dimethylaminopropyl) carbodiimide (EDC) reaction was 89 % and 78 % inhibition of S. 
epidermidis, respectively. Roosjen et al. [28] investigated bacterial adhesion to poly(ethylene 
oxide) (PEO)-brushes. They found bacterial adhesion decreased on this polymeric surface and 
suggested attenuation in Lifshitz–Van der Waals attractive energies was responsible for the 
reduction in bacterial adhesion. 
The bactericidal surfaces are normally fabricated as a coating that is loaded with antimicrobial 
agents, such as silver, zinc, copper, and chitosan. Silver is the extensively studied metal for 
eliminating microorganisms due to its high efficacy, but silver is often used as an alloy coating 
because of its high cost and the corrosion issue. Other coatings, such as hydroxyapatite (HA) 
and quaternary ammonium compounds (QACs), are often reported as anti-microorganism 
agents [29, 30]. Zhi et al. [31] evaluated a dual-function thin film coating consisting of two 
layers: one layer as a reservoir to release the antimicrobial agents and the second layer of a 
nanoparticle cap with immobilized antimicrobial properties. The following Table 2 shows some 
examples for a different type of antimicrobial coatings.  
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Table 2 Antimicrobial coating examples (David Campoccia et al. [24]) 
Type of coating Coating material Tested bacteria References 
Antiadhesive 
coating 
2-Methacryloyloxyethyl 
phosphorylcholine (MPC) 
polymer (Polymerization) 
Pseudomonas (p.) 
aeruginosa,  S. aureus, 
S. epidermidis 
[32] 
Poly(2-methyl-2-oxazoline) 
(PMOXA) (Polymerization) 
Escherichia (E.) coli   
Trimethylsilane (Plasma 
polymerization) 
S. epidermidis [33] 
Bioactive 
coating 
Chlorhexidine (1,10-
hexamethylenebis[5-(4-
chlorophenyl)biguanide]) on 
PE (Cold Plasma) 
E. coli, S. aureus [34] 
Silver/hydroxyapatite 
composite coatings (Polymer 
impregnating) 
E. coli, S. epidermidis [35] 
Nitric oxide 
(NO)-releasing 
coatings 
NO-storing Zn(2þ)-exchanged 
zeolite in a 
polytetrafluoroethylene 
polymer 
P. aeruginosa, S. aureus [36] 
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Type of coating Coating material Tested bacteria References 
Quaternary ammonium (QA)-
functionalized silica 
nanoparticles 
P. aeruginosa, S. aureus [37] 
Reactive oxygen 
species-
releasing 
coatings 
Nanofibers of 
polycaprolactone (PCL) 
incorporating calcium peroxide 
(Electrospinning technique) 
E. coli, S. epidermidis [38] 
Carboxyl-ebselen immobilized 
polyethylenimine (e-PEI) and 
alginate (Alg) alternatively 
assembled layer-by-layer 
(LbL) film 
E. coli, P. aeruginosa, 
S. aureus 
[39] 
 
2.1.2 Fabrication of a coating surface 
The coating surfaces can be fabricated through different methods such as electrostatic 
deposition [40], electrophoretic deposition [41, 42] and chemical vapour deposition (CVD), 
plasma polymerization and physical vapour deposition (PVD) [40, 43], [44].  
In the electrostatic deposition method, a negative electrical charge is placed on the coating 
particles either by direct charging or by ionizing the air around the coating particles. The coating 
particles are then attracted to the surface when passing alongside the surface. A voltage source 
between 60 to 125 kV is typically used in the electrostatic deposition method [45]. The 
electrophoresis method is a combination of electrophoresis and deposition processes. The 
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electrophoresis is based on the motion of electrically charged particles in a suspension using an 
electric field. This method is used only to deposit ionic particles [46, 47]. 
The chemical vapour deposition (CVD) technique is used to produce layers with a thickness of 
0.1 to 10 µm from the gas phase using a chemical reaction. The precursor can be either organic 
or inorganic materials. The solid precursors are converted into gaseous phase before deposition 
on the surface of the material to be coated. The deposition process occurs inside a chemical 
reactor. The quality of coating by the CVD technique is subjected to various steps within the 
process including adsorption and desorption of precursors, surface reaction, surface dilution, 
nucleation, growth of the critical nuclei, layer formation and aging process. Thermal CVD and 
plasma CVD are two common methods based on the CVD technique [48, 49].  
The plasma polymerization technique is used to fabricate a polymeric coating of organic or 
organometallic materials on the surface of substrates. The plasma polymerization process 
occurs inside a reactor. The reactor has two internal electrodes: one electrode on which the 
substrate is placed is grounded; the other electrode is connected to a radio frequency power 
supply. The organic monomer gas, alone or combined with a carrier gas (e.g. argon) is fed into 
the reactor to form plasma then deposited as a coating on the surface of the substrate.  The 
plasma polymerization method has an advantage of producing coatings with a controlled 
thickness of approximately 2 µm and acceptable adhesion to a variety of substrates. However, 
plasma polymerization requires reactors with very good vacuum integrity. Control and 
measurement of the pressure in the plasma polymerization reactor is also a challenging task as 
the pressure in the reactor could change significantly when the discharge is turned on [49]. 
The PVD method is a process to fabricate a thin film on a substrate. In this method, the atoms 
or molecules of the target material are vaporised and then deposited onto the substrate in 
vacuum conditions. The method can be used to deposit metals, compounds and alloys. The 
advantages of this method are its accuracy in depositing a very thin coating and its controlled 
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properties which are required for antimicrobial purposes. The PVD process can be realised 
through vacuum evaporation, sputter deposition, ion plating and pulsed laser deposition [50]. 
Figure 2 below shows a simplified configuration of the physical sputtering deposition 
technique. 
 
Figure 2 The physical sputtering deposition process. a- power supply, b- cathode, c- ion, 
d- substrate and e- plasma [49] 
The magnetron sputtering deposition has also been explored to fabricate antimicrobial coating 
surfaces.  Magnetron sputtering deposits the target atoms in a non-thermal vaporization process. 
In this technique, a magnetic field parallel to the cathode surface traps the electron and restrict 
the primary electron motion into the vicinity of a cathode. The magnetic field in this technique 
only influences the plasma electrons but not the ions. The high efficiency of ionization 
mechanism allows the process running at a very low pressure (approximately 0.15 Pa) with 
high current densities and at a low voltage resulting in a high sputtering rate. This technique 
provides a faster deposition rate compared with other techniques and can be used to create very 
strong adhesive coatings on substrates with very complex geometries including biomedical 
equipment [49, 51]. The following Figure 3 displays a simplified planar configuration of the 
19 
 
magnetron sputtering deposition technique [49]. 
 
Figure 3 Planar magnetron sputtering sources a- magnets, b- pole piece, c- anode and d- cathode 
[49] 
 The magnetron sputtering deposition has the following advantages: a- a wide range of materials 
including metals, alloys and even components can be deposited, b- very durable deposition, 
c- the flexibility of deposition conditions which allow great control over the properties of the 
deposited coatings. 
2.2 Antimicrobial nanomaterials 
The nanoparticles (NP) are the material with a crystal form at a size less than 100 nm. Although 
the NPs have the same chemical composition as the bulk materials, they show different 
properties such as different conductivity and melting points. The nano size of NPs and the 
quantum mechanic effects contribute to the variation in these properties [52]. The NPs for 
antimicrobial applications have attracted attention by researchers for decades. One of the main 
advantages of NPs compared with its bulk materials especially for antimicrobial purposes is 
related to their morphology: a high ratio of surface area to volume due to their nanoscale size. 
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Ag, Au, copper (Cu), titanium oxide (TiO2) and zinc oxide (ZnO) have been studied extensively 
for their antimicrobial purposes.  
2.2.1 Synthesis of NPs 
The NPs can be synthesized through various methods. The most common methods for synthesis 
of NPs are solvothermal, sol-gel, precipitation, sonochemical, microwave‑assisted, laser 
ablation and combustion [53].  
The solvothermal method is the most common method for synthesising NPs. In this method, 
NPs are formed in a small Teflon lined SS autoclave in a high pressure and temperature in the 
presence of a solvent. In the case of using water as the solvent, the method is called 
hydrothermal. The morphology of the NPs can be controlled by selecting different solvents, 
surfactants, pressures and temperatures. Metal oxides NPs such as zinc oxide (ZnO) and 
titanium oxide (TiO2) can be readily synthesised by this method. 
Precipitation and sol-gel depend on the Brownian motion of particles. The Brownian motion is 
a force keeping the particles suspended in liquid or gas. This force can be exerted on the 
particles in the form of thermal energy and it is normally greater than gravity in order to suspend 
the particles in the fluid. Two possible scenarios exist for the colloidal particles. In the first 
scenario, a bond is established between the colloidal particles upon collisions, leading to 
particles aggregation (known as coagulation or flocculation). The aggregated particles are then 
deposited at the bottom of the reactor. This is the basis for precipitation method for synthesising 
the NPs. Co-precipitation occurs when a couple of different materials are used. The second 
scenario applies to the sol-gel method. No bond is established between the colloidal particles 
when colliding. However, a solution colloid is normally produced after a few days and it is used 
as a precursor to building NPs network. The sol-gel method is often used to synthesize metal 
oxide NPs (e.g.TiO2) and can also be used to make discrete NPs or polymers [54].  
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Ag NPs have been synthesised by different methods, each method with advantages and 
disadvantages. The common method to synthesise Ag NPs is to reduce silver nitrate (AgNO3) 
by sodium borohydrate (NaBH4) or sodium hydroxide (NaOH). It is also common to use a 
capping agent to prevent aggregation and agglomeration of the NPs during the synthesis 
process. Aggregation happens when single particles are strongly bonded with each other, and 
the surface area of the resulting aggregated particles is less than the summation of the surface 
area of individual particles. Agglomeration, on the other hand, occurs when the bonding 
between single particles is not strong. The resulting surface area of the agglomerated particles 
is equal to the summation of the surface area of individual particles. Typical capping agents 
include polyethylene glycol (PEG), ethylenediaminetetraacetic acid (EDTA), polyvinyl 
pyrrolidone (PVP) and polyvinyl alcohol (PVA). 
Rose Amal et al. [55] have synthesised Ag-doped TiO2 NPs and evaluated the as-prepared NPs 
against E. coli. They have shown the NPs at a concentration of 50 mg/l killed 100 % of E. coli 
in 6 h.  The antimicrobial mechanism of action is suggested to be silver ions produced from the 
synthesised NPs. The Ag ions have the bactericidal efficacy by binding them with thiol, sulfur 
and phosphorus groups of the bacterial cell wall to produce holes on the cell wall, which allow 
the Ag ions to enter the bacterial cell and bind with DNA which leads to cell death [56, 57]. 
A green method, using non-toxic and environmentally-safe chemicals, was used to synthesise 
Ag NPs by Vigneshwaran et al. [58]. In this method, AgNO3 was reduced by starch in a one-
step process at 121 °C and 15 psi. However, the synthesised NPs were polydispersed. The 
Ag NPs can also be synthesized using UV light. Guang-nian et al. [59] synthesised very small 
Ag NPs (4 to 6 nm) by irradiation of [Ag(NH3)2]+ with UV light in the presence of PVP as the 
reducing and stabilizing chemicals. 
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2.2.2 Antimicrobial mechanisms of NPs 
The NPs use various mechanisms to produce localised toxicity for killing microorganisms such 
as generation of active ions and reactive oxygen species (ROS). Metallic Ag has been used 
historically in a medical application, without knowing the exact mechanism of the action, over 
thousands of years. Different compounds of Ag such as nitrates and sulphides have also been 
used in dentistry, treatment of wounds and water treatment [60-62]. The mechanisms of the 
antimicrobial function of Ag NPs have been investigated by the scientists, however, it is still 
an area of debate [63-66].  
One of the antimicrobial mechanisms for silver NPs is related to the accumulation of the 
metallic silver NPs on the bacterial membrane. The accumulated NPs form aggregation within 
the bacterial membrane which disturbs bacterial normal interactions leading to bacterial death 
[67-69]. The average size of bacteria is 1 μm (e.g. E. coli), while the NPs are less than 100 nm 
and normally have a non-uniform size distribution. This mechanism is only applicable to the 
fractions of the particles which are in nano-metre size.  
Another antimicrobial mechanism of silver is related to ROS generated from silver-containing 
products [70, 71]. The mechanism of bacterial inactivation by ROS involves different actions: 
(1) The ROS induce pits on the bacterial membrane, which lead to leaking the intracellular 
organelles out of the bacteria; (2) The ROS may penetrate into bacteria internal structures 
through these pits and then bind with DNA and enzymes, which prevents reproduction of the 
bacteria.  
The third mechanism of the action for silver NPs is ascribed to Ag+ ions produced from silver 
[72-74]. In this mechanism, the metallic silver NPs generate Ag+ by oxidative dissolution upon 
reaction with water. Ag+ is an active cation and can bind with thiol and amino groups of 
bacterial proteins, resulting in deactivating the bacteria. 
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The photocatalytic materials such as TiO2 and ZnO in the NP form have been intensively 
investigated for antimicrobial applications due to ROS emission upon illumination with light. 
One of the motivations for using these materials is their relatively low cost, which is ideal for 
making antimicrobial coatings. The photocatalytic material absorbs photons (hν) with an energy 
equivalent or greater than their band gap (EG). The band gap is defined as the potential 
differences between the conduction band (CB) and valence band (VB). Upon absorption of the 
photon by the photocatalytic NPs, the electron from VB promotes to CB, which results in the 
formation of CB electron (e-) and a VB hole (h+). The VB hole, in fact, is lack of the electron 
in the CB. The electron-hole pair then simultaneously reacts with the surrounding molecules, 
for example, water (H2O) and oxygen (O2),  to form ROS through the following equations [75]. 
e + O   →   O•      Eq (1) 
h + H O  → •OH + H     Eq (2) 
O• + H  → HO•            Eq (3) 
HO• + H + e  →  H O     Eq (4) 
TiO2 and ZnO are both considered as semiconductors with a wide band gap. The band gap 
energy for TiO2 is 3.2 eV, which requires light with a wavelength of equal to or less than 388 nm 
to be excited, while a light with a wavelength equal to or less than 369 nm is required to induce 
ZnO with a band gap of 3.37 eV. The wavelengths of 369 and 388 nm are both in the UV light 
wavelength range. In nature, only a small fraction of the solar light spectrum is in the UV 
wavelength range. The artificial UV lights can damage eyes and skins due to a very high energy 
level when the lights are used for medical applications.  
The photocatalytic activity of TiO2 and ZnO can be modified so that photocatalysis occurs in a 
higher or visible range of light wavelengths (higher than 400 nm). There are three main theories 
for this process: bandgap narrowing, impurity energy level and oxygen vacancies [76]. The 
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bandgap narrowing method is the most common method of doping NPs with another 
element(s). The doping process leads to a reduction in the CB energy or an increase in the VB 
energy or both. For example, Asahi et al. [77] have narrowed the band gap of TiO2 NPs using 
a nitrogen (N) dopant. Doping of TiO2 with different elements has been explored to produce 
novel NPs for antimicrobial evaluation. The following table presents doped TiO2 NPs for 
antimicrobial applications. The table also includes doped novel materials whose photocatalytic 
activity is in the visible light condition.  
Table 3 TiO2 NP dopants for antimicrobial and photocatalytic applications 
Authors Dopants Bacteria tested or photocatalytic 
evaluation 
References 
Duran-Alvares et al. Au, Ag and Cu - [78] 
Gopinath et al. Au, Pt S. pneumoniae, B. subtilis, 
S. dysenteriae, P. aeruginosa, 
E. coli, K. pneumoniae 
[79] 
Hamad et al. Ag E. coli [80] 
Jia et al. Bi2WO6 E. coli [81] 
Sood et al. Bi2O3 degradation of an aqueous 
solution of ofloxacin drug 
[82] 
Dhanapandian et al. Sn Bacillus (B.) subtilis  [83] 
Dhineshbabu et al. SiO2 S. aureus and E. coli [84] 
Leyland et al. F, Cu S. aureus (ATCC 6538) [85] 
Parvathi et al. MgO, Ag E. coli and B. subtilis [86] 
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Authors Dopants Bacteria tested or photocatalytic 
evaluation 
References 
Wang et al. Y, B E. coli and S. aureus [87] 
Sutassana et al. V-N pair degradation of organic pollutants [88] 
He et al. Sr-Ag E. coli and S. aureus [89] 
Wang et al. Zn, Ce, Y, B, 
Zn/RE, Zn/B 
- [90] 
Raja et al. N, (porous TiO2) 
 
Photocatalysis against methylene 
blue degradation 
[91] 
Duo et al. BiOCl photocatalysis against 
degradation of phenol 
[92] 
Tobaldi et al. Cu - [93] 
Naghibi et al. Fe E. coli, S. aureus, 
Saccharomyces cerevisiae 
(yeast) and Aspergillus niger 
(fungus) 
[94] 
Prabha et al. Cd, (AC-Cd) pair Bacillus (B.) subtilus, S. aureus, 
E. coli, Pseudomonas 
aeruginosa (P. aeruginosa) 
[95] 
Lin et al. I E. coli [96] 
Zhang el al. Na, Pd - [97] 
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Authors Dopants Bacteria tested or photocatalytic 
evaluation 
References 
Yang et al., Wang et 
al. 
B2O3, B, Zn Candida albicans (yeast), E. coli, 
S. aureus 
[98-100] 
Kongsong et al. N, SnO2 E. coli, Salmonella typhi, 
S. aureus 
[101] 
Yuzheng et al. C, (C, B) pair E. coli and S. aureus [102] 
Wang et al. S Photocatalysis against methyl 
orange 
[103] 
Duran-Alvares et al. Au, Ag, Cu and 
Ni 
Aliivibrio fischeri (marine 
Gram-negative bacteria) 
[78] 
Amna et al. Co S. aureus, Salmonella typhi [104] 
Ramya et al. Eu, Ag P. aeruginosa [105] 
Yu et al. N E. coli [106] 
 
The antimicrobial activity of ZnO NPs is dependent on several factors such as shape, particle 
size and particle charge. Different shapes of ZnO NPs are synthesised, such as sphere [107], 
flower, dumbbell [108], rod [109] and flake [110] shapes. Some shapes are presented in the 
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following images from Talebial et al. [111]. 
  
Figure 4 SEM images of ZnO NPs with different shapes synthesised by Solvothermal method. 
a- ZnO NPs synthesised using 1-hexanol as solvent, b- ZnO NPs synthesised using ethylene 
glycol as solvent, c- ZnO NPs synthesised using water as solvent  [111] 
ZnO NPs, similar to TiO2 NPs, have been explored for their antimicrobial properties. The 
following table shows selective ZnO NPs synthesised for antimicrobial evaluations. 
 
Table 4 Selected doped ZnO NPs for antimicrobial evaluations 
Authors Dopants Synthesis method Bacteria tested References 
Azizi et al. Ag green method E. coli, S. aureus, 
B. subtilis, 
[112] 
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Authors Dopants Synthesis method Bacteria tested References 
S. epidermidis, 
Salmonella choleraesuis, 
Acinetobacter anitratus 
Sharma et al. Mn, Fe co-precipitation E. coli, S. aureus, 
K. pneumoniae, 
Salmonella typhi, 
P. aeruginosa, B. subtilis. 
Candida albicans, 
Aspergillus fumigatus, 
Cryptococcus neoformans, 
Trichophyton 
mentegrophytes. 
[113] 
Arul Mary et al. Ce-Cu microwave 
assisted 
combustion 
E. coli, P. aeruginosa, 
S. aureus, K. pneumonia, 
B. subtilis 
[114] 
Ravichandran et 
al. 
(Ag-
Mn) 
and 
(Ag-
Mn-F) 
combustion E. coli, Klebsiella Oxytoca [115] 
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In summary, healthcare-associated infections caused by antimicrobial resistance bacteria is a 
global challenge. The SS as the main material used in hospital setups do not have antimicrobial 
properties and there is an increasing demand of creating coatings to improve its antimicrobial 
properties. Several strategies have been employed to produce antimicrobial coatings, however, 
more efficient coatings by combining different technologies are continuously pursued. Metal 
alloy coating has been used for other applications, but very few research efforts are placed for 
the antimicrobial application. 
 The nanomaterials with their special properties compared with bulk materials have shown 
promising results in combating antimicrobial resistance bacteria. Several different types of 
nanoparticles with a variety of morphologies have been synthesised by different methods. ZnO 
NPs-derived NPs have received attractive attention in the antibacterial arena, especially under 
the illumination of visible light. 
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Abstract 
Cr-Ag coatings for antimicrobial surface applications were fabricated by magnetron sputtering. 
The coating microstructure and mechanical properties were characterised using XPS, XRD, 
FESEM, TEM and nanoindentation measurement as a function of Ag content. The 
antimicrobial efficacy of these Cr-Ag coatings was evaluated against the pathogenic bacteria 
Escherichia coli and Staphylococcus aureus, revealing varied levels of bacterial killing. This 
study warrants further investigation into the antimicrobial mechanism of action of silver and 
future applications of Cr-Ag as antimicrobial coating for healthcare settings. 
Keywords: antimicrobial surfaces, coating, silver, chromium 
3.1 Introduction 
Nosocomial bacterial infections are a significant reason for morbidity and mortality worldwide. 
Estimated 4,131,000 individuals within Europe acquire nosocomial infection each year [1]. 
Together these infections result in 147,000 deaths, either directly or indirectly [2]. The rates of 
nosocomial infections are also increasing due to the development of bacterial strains which are 
resistant to available antibiotics. Within hospitals, bacteria are capable of surviving on a range 
of surfaces thereby facilitating transmission. This is despite the widespread utilisation of 
terminal cleaning following discharge of patients. Nosocomial infections commonly arise from 
bacteria present on surfaces such as beds, doorknobs, surgical equipment and medical implants. 
Many of these are made of stainless steel (SS) due to its good corrosion resistance and high 
hardness, as well as low cost and ease of cleaning. However, SS is not antimicrobial [116]. 
Bacteria antiadhesive surfaces [117-119], intrinsically antimicrobial biomaterials [120, 121], 
bioactive antimicrobial coatings [34, 38, 122-125], nanostructured biomaterials [126, 127] and 
bioactive molecules [24, 128, 129] all form the current surface antimicrobial arsenal. However, 
these surfaces are generally polymer-based, mechanically weak and susceptible to heat and 
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environmental damage and so they are not suitable for biomedical applications. Therefore, 
development of an antimicrobial coating which maintains the advantageous mechanical 
properties of a material such as SS would be highly beneficial in preventing the transmission 
of bacterial infections within healthcare settings. 
Silver (Ag), in metallic [61], salt [130] and nanoparticle forms [131, 132] has proven to be 
antimicrobial. Several studies have suggested silver ions (Ag+) released from the dissolution of 
metallic silver to be the basis for its antimicrobial effects [44, 56, 68, 132]. Metallic silver is a 
noble metal with the standard reduction potential (E°) of 0.7996 V [133]. Upon contact with 
water molecules in the environment, silver is oxidized by dissolved oxygen (O2) in the water 
and generates a silver ion (Ag+) that serves as an active antimicrobial species [44, 68]. Silver is 
an attractive antimicrobial material due to its potent antimicrobial activity, relatively low 
toxicity to humans, and durability in the environment. However, employing pure silver (as an 
antimicrobial agent) in biomedical applications is limited. This is primarily due to the increased 
cost and decreased corrosion resistance of silver by comparison to SS. Further, pure silver could 
also cause the uncontrolled release of the Ag+ ions, which could also result in localised toxicity 
[24].  
Silver-containing surfaces for biomedical application have been investigated in multiple 
studies. Textiles containing Ag [134], Ag-doped titanium dioxide (TiO2) surfaces [135-137], 
Ag-doped zinc oxide (ZnO) nanocomposite textiles [138], Ag-copper (Cu) alloy [139] and Ag-
hydroxyapatite [140] are several examples of silver-containing surfaces investigated as 
antimicrobial surfaces. The selection of materials and synthesis methods to produce precise thin 
coatings with the required mechanical properties are important factors in manufacturing 
antimicrobial coatings suitable for healthcare applications.  
Hard alloy coatings with a small, optimised quantity of silver (acting as a reservoir for release 
of the Ag+ ions) could be engineered onto SS for biomedical applications. Here, we report the 
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synthesis and characterisation of chromium-silver (Cr-Ag) alloy coatings. Chromium (Cr)-
based coatings were utilised as they show excellent mechanical characteristics such as hardness 
and corrosion resistance. However, Cr has not been extensively characterised as an 
antimicrobial agent. 
3.2 Materials and methods 
Magnetron sputtering is an advanced method for producing very thin coatings with controlled 
properties. This technique was used to deposit the antimicrobial alloy coatings onto glass 
microscope slides (76 x 26 mm and a thickness of approximately 1 mm), and the microstructure 
properties of the coatings were characterised. In this experiment, a magnetron sputtering system 
(closed field unbalanced UDP650, Teer Coatings Ltd., UK) was utilised to deposit the Cr-Ag 
coatings. The magnetron with the configuration of a pure Ag (99.99 %) target, two Cr (99.5 %) 
target and a dummy target were used in this process. The dimensions of the targets were 345 
mm x 145 mm x 8 mm. The substrates were cleaned using an ultrasonic bath, polished then 
dried by nitrogen gas. The substrates were placed on the holder then the distance between the 
substrate and target adjusted to 170 mm. The pulse DC with a frequency of 250 kHz was used 
to bias the substrates. The chamber pressure reduced to a background pressure of 4 x 10-4 Pa. 
The high purity Argon (Ar) gas with a flow rate of 50 sccm and pressure of 0.18 Pa was added 
to the chamber through mass flow controller (MKS). The Cr-Ag coating deposition process 
occurs in two steps of plasma ion cleaning followed by Cr-Ag layer deposition. The substrates 
were cleaned in order to remove contaminants from their surfaces hence superior adhesion of 
coatings. The substrates were cleaned by ion etching at a temperature of approximately 200 °C 
and a bias voltage of -450 V for 30 minutes. After that, the Cr-Ag coatings with approximately 
0.8 µm thickness were prepared by co-sputtering the Cr target and the Ag target. The sputtering 
power of the Cr target was 1.3 kW at a fixed target current of 4.0 A. The bias voltage of -60 V 
was used during the deposition stages. In order to prepare the Cr-Ag coatings with different 
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percentages of Ag, the Ag target currents of 0, 0.3 and 1.0 A were selected in the deposition 
stage. The deposition times between 30 and 60 min was used to ensure the total coating 
thickness reached approximately 0.8 μm. The pure Ag and pure Cr coatings were also prepared 
by only sputtering Ag or Cr at a target current of 2.0 A for 30 min. All the depositions were 
carried out at the ambient temperature, with the substrate holder rotating at a speed of 10 rpm. 
The composition, microstructure and mechanical properties of as sputtered coatings were 
examined using XPS, XRD, FESEM, TEM and nanoindentation tests. 
3.3 Results  
3.3.1 XPS 
The X-ray photoelectron spectroscopy (XPS) is a tool to define and study the chemical bonding 
structure in the coatings. To do so, Al kα radiation (photon energy, hν = 1,468.68 eV) was 
applied as the excitation source. The high resolution (HR) scans were carried out at 100 eV 
while the spectrometer calibration was performed using binding energy levels of Au4f7 (83.96 
eV), Ag3d5 (368.21 eV) and Cu2p3 (932.62 eV). From the XPS graphs in Fig. 1, the 
deconvolution of HR spectra of Cr3p clearly indicates the presence of metallic chromium and 
chromium (III) oxide [141]. The existence of Cr (III) oxide is further confirmed by the 
deconvolution of O 1s HR spectra [141] indicating the highly oxidizing nature of the Cr-Ag 
coatings since the enthalpy of formation of Cr (III) oxide is quite high (-1134.70 kJmol-1 [142]). 
Furthermore, Cr3p and Ag3d5 spectra clearly show the absence of bonding between Cr and Ag. 
Studies on the Cr-Ag system by Hindrichs [143], Allen [144] and Grigorev et al. [145] confirm 
the immiscibility of Cr and Ag in both solid and liquid states indicating the absence of any 
stable intermediate phases. 
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Figure 1 Deconvoluted HR spectra of (a) Cr3p, (b) Ag3d5 and (c) O1s 
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3.3.2 XRD 
The X-ray diffraction (XRD) patterns for the Cr-Ag coatings along with pure Ag and Cr 
coatings are shown in Fig. 2. Diffraction peaks corresponding to Ag are absent in the pure Cr 
coating [Fig. 2(a)] and even after the addition of 4.83 wt.% Ag [Fig. 2(b)]. However, diffraction 
peaks corresponding to face-centre cubic (FCC) Ag (111) is observed in Cr-Ag coating surfaces 
[Fig. 2(a)] after addition of 15.23 wt.% Ag, accompanied by a slight shift towards higher 
2θ angles. The majority of the diffraction peaks are representative of BCC polycrystalline Cr. 
This can be further confirmed from selected area electron diffraction (SAED) patterns. The 
SAED analyses were carried out using transmission electron microscopy (TEM) micrographs 
presented in Fig. 4. The structure and morphology of the pure Ag and Cr coatings were also 
investigated by focused ion beam microscopy (FIB, FEI xT Nova Nanolab USA) and TEM 
(Philips CM 200). Figure 3 presents the ion-induced secondary electron (SE) images. Pure Ag 
coating consists of a coarse-grained structure with a rough coating surface, whereas pure Cr 
coating consists of the columnar grained structure. The size of the columnar grains in the Cr 
rich coatings decreases with the addition of Ag which can be seen from FIB micrographs in 
Fig. 3(d) and in the TEM micrographs in Fig. 4. 
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Figure 2 GI-XRD patterns of (a) Cr-Ag coatings and (b) Pure Cr and Ag 
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Figure 3 Ion induced SE micrographs of: (a) Pure Ag, (b) Pure Cr, (c) Cr-Ag 4.83 wt.% and (d) 
Cr-Ag 15.23 wt.%. Substrate refers to microscope glass, the platinum (Pt) coating has been 
used to facilitate SEM measurement.  
 
 
Figure 4 Bright field TEM micrographs of (a) Cr-Ag 4.83 wt.% and (b)Cr-Ag 15.23 wt.% 
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3.3.3 Nanoindentation 
The nanoindentation tests were performed using a Hysitron Triboindenter (Hysitron TI900, 
USA) to determine several mechanical properties of the coatings, including hardness (H), 
elastic modulus (E), elastic strain to failure (H/E), plastic deformation resistance (H3/E2) and 
energy required to plastically deform the coating (Ep). The coating samples were indented, 
where the load-unload segments were carried out at a maximum load of 8 mN with each in 10-
second duration in a linear fashion. Each sample was subjected to more than twelve indents at 
different locations. The Oliver-Pharr method was utilised to determine the modulus and 
hardness [146-148] and are presented in Table 1. From the results, it can be seen that an increase 
in the Ag content in Cr-Ag coatings leads to an increase in the hardness and a decrease in the 
modulus of the coatings by almost 24 GPa. As a result, the H/E and H3/E2 ratios increase by 
almost 1.5 and 2 times, respectively. This means a potential increase in coating toughness, 
which is further confirmed by an increase in plastic deformation energy, Ep, derived from the 
area under the load-displacement curves.  
Table 2 Nanoindentation measurements (hardness (H), elastic modulus (E), elastic strain to 
failure (H/E), plastic deformation resistance (H3/E2) and energy required to plastically deform 
the coating (Ep). Data are presented as mean ± standard deviation 
Samples H (GPa) E (GPa) H/E H3/E2 (GPa) Ep (NJ) 
Pure Ag 1.3 + 0.32 103.7 + 2.8 0.012536 0.000204 0.11 
Pure Cr 9.0 + 0.58 208.6 + 4.9 0.043145 0.016753 0.44 
4.83 % Ag 7.1 + 0.43 132.3 + 3.5 0.053666 0.020448 0.34 
15.23 % Ag 8.1 + 0.45 108.3 + 3.3 0.074792 0.04531 0.41 
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3.3.4 Antimicrobial 
A modified method based on the Japanese standard JIS Z 2801:2010 [149] was used to 
determine the antimicrobial efficacy of samples. Microscope slides coated with pure Cr, pure 
Ag, 4.83 % Ag, or 15.23 % Ag and a glass microscope slide without any coating were used. 
The pure Ag coating was used as a positive control and the glass slide without coating was used 
as a negative control. The antimicrobial properties of each surface were assessed against both 
the Gram-negative bacterium Escherichia (E.) coli MG1655 and the Gram-positive bacterium 
Staphylococcus (S.) aureus USA300.  
Cells were grown to the mid-logarithmic phase in Mueller Hinton Cation-Adjusted media 
(Becton Dickinson), prior to dilution in phosphate buffered saline (PBS) solution to 107 colony 
forming units per ml (CFU/mL) for use in each assay.  
The coatings were sterilized by wiping with 100 % ethanol and left to dry inside a biosafety 
cabinet. Each antimicrobial test was performed inside a sterilized petri-dish, with moist 
Whatman filter paper placed at the bottom of the petri-dish to provide sufficient humidity and 
to avoid evaporation of PBS used in the assay. Four glass microscope slides were placed on the 
paper filter, to ensure the test coatings did not contact the paper and absorb the test solution. 50 
μL of diluted bacteria (107 CFU/ml) was added to the coating surface. A sterile glass 
microscope slide was placed on the coating to spread the bacteria evenly on the surface of the 
coating. The petri-dishes were then placed at 37 °C for 1 hour. Upon completion of the 
treatment, PBS was used to wash the coating surface and cover slide. The collected samples 
were spread on luria bertani 1.5 % agar plates allowing for bacterial enumeration and 
determination of antimicrobial efficacy. Bacterial survival after 1hr was assessed on each 
surface in at least biological triplicate for at least 3 separate coated slides of each Cr-Ag 
formulation (Figure 5). Statistical analysis was performed by one-way ANOVA by comparing 
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the survival of each surface relative to the glass control, with significance indicated by * for P 
<0.05; *** for P <0.001; and **** for P <0.0001.  
The pure Ag coatings were very effective in killing E. coli, resulting in 2.74 log CFU reduction 
in survival relative to the glass control, while the pure Cr showed 0.26 log CFU reduction of 
survival cells . Of the two Cr-Ag alloys tested, the coating with 4.83 % Ag exhibited greater 
antimicrobial activity (0.82 log CFU reduction) compared to the glass control, with a 0.32 log 
CFU reduction of viable cells the Cr-Ag coating with 15.23 % Ag. The antimicrobial efficacy 
of the coatings followed a similar pattern with S. aureus, however, all surfaces were less 
antimicrobial against this organism, with the pure silver resulting in an 0.92 log CFU reduction 
and the 4.83 % Ag and 15.23 % Ag coatings resulting in 0.67 log CFU reduction and 0.26 log 
CFU reduction, respectively.  
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Figure 5 Antimicrobial efficacy of the Cr-Ag surfaces against E. coli (MG1655) and S. aureus 
(USA300). Statistical analysis was performed by one-way ANOVA by comparing the cell 
survival on each surface relative to the glass control, with significance indicated by * for P 
<0.05; *** for P <0.001; and **** for P <0.0001 
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3.4 Discussion  
Despite the inclusion of silver as an antimicrobial in wound dressings, the exact antimicrobial 
mechanism(s) of silver remain unclear. Several studies [44, 56, 68, 132] have suggested that 
the possible mechanism of action for metallic silver might be via Ag+ ions, which can be 
generated by oxidative dissolution of silver. These Ag+ ions can then bind phosphorus, thiol 
and sulfur groups of the bacterial cell membrane, increasing permeability [56]. Ag+ ions may 
also be able to penetrate the membrane, and bind to DNA, thereby inhibit DNA replication and 
resulting in cell death [56, 57, 150-153]. Our results also demonstrate that Ag+ ions released 
from the coating surface may be the key factor for reducing viable cells.  
According to the Japanese standard JIS Z 2801:2010 [149], the treatment time for the bacteria 
on the sample surfaces is 24 + 1 h. However, examination of bacterial survival after 24 h on 
Cr-Ag coatings using either 4.83 %  or 15.23 % Ag resulted in 4 log CFU reduction against 
both tested bacteria (data not presented).  Rather, in the present study, the treatment time was 
set to be 1 h to enable comparison of the antibacterial efficacy for different Cr-Ag coatings. 
Also, within a hospital setting, it is likely that a time-frame for the bacterial killing of more than 
1 h would be beneficial for reducing bacterial transmission from contaminated surfaces. Our 
analyses demonstrated bacterial survival had an order of 15.23 % Ag > 4.83 % Ag  >100 % Ag. 
Whilst this was consistent across both the Gram-negative bacterium E. coli and the 
Gram-positive bacterium S. aureus, the level of survival for S. aureus on the surfaces was 
greater than that for E. coli . This may indicate that the differences in the cell envelope structure 
play a role in resistance to killing on the tested surfaces. Gram-positive bacteria featuring a 
single membrane and a thicker protective peptidogylcan cell wall, and this is in contrast to the 
cell envelope of Gram-negative bacteria, which features both inner and outer membranes with 
a thin peptidoglycan layer between the membranes [5, 154]. Further analysis is required to 
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determine the relative antibacterial efficacy of these surfaces against different bacterial genera,  
including examples of both Gram-positive and Gram-negative organisms.  
3.5 Conclusion 
In conclusion, Cr-Ag coatings were manufactured by magnetron sputtering to evaluate their 
applicability as an antibacterial coating on medical surfaces. The nanoindentation 
measurements revealed an acceptable level of mechanical properties for these coatings. The 
results confirmed that an increase in the Ag content in Cr-Ag coatings will increase the hardness 
and decrease the modulus of the coatings. As a result, a potential increase in coating toughness 
was observed, and confirmed by an increase in plastic deformation energy (Ep). Consistent with 
previous studies which have characterised the antimicrobial nature of Ag, the 100 % Ag coating 
had a very strong antimicrobial efficacy against E. coli. Contrary to expectations, the 15.23 % 
Ag coating did not have a greater antimicrobial efficacy than the 4.83 % Ag coating against 
either E. coli or S. aureus. Together, this study confirmed the antimicrobial properties of Cr-Ag 
coatings, which can be adjusted by varying the Ag content. This warrants further investigation 
into their mechanism of antimicrobial action and future potential as an antimicrobial coating 
for healthcare settings. 
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Abstract 
 ZnO nanoparticles doped with I and Ag were prepared via a solvothermal method. 
Characterizations of as-synthesised samples were carried out using X-ray diffraction (XRD), 
X-ray photoelectron spectroscopy (XPS), UV-Vis spectrometry, Photoluminescence (PL), 
transmission electron microscopy (TEM) and scanning electron microscopy (SEM). The 
nanoparticles exhibited wide-spectrum light absorption from ultra-violet (UV) to visible light. 
The antimicrobial efficacy was evaluated against Escherichia coli (MG1655) and 
Staphylococcus aureus (USA300) as models of Gram-negative and Gram-positive 
microorganisms respectively. The double-doped nanoparticles had demonstrated their potent 
efficacy against both types of microorganisms and they may have great potential application in 
combating infectious diseases. More importantly, the mechanisms underlying the antimicrobial 
samples were revealed: synergistic effect of reactive oxygen species (ROS) generation and Ag+ 
release. However, ROS generation was more dominant in the I:Ag:ZnO sample, while Ag+ 
release played an important role in the Ag:I:ZnO. We also confirmed that a small fraction of 
Ag in the AgO form in the sample was enough to eliminate these pathogenic bacteria.  
Keywords: antimicrobial; nanomaterial; ZnO; visible light 
4.1 Introduction 
Healthcare-associated infection (HCAI) caused by antimicrobial-resistant bacteria is a global 
health challenge. For example, more than 4 million individuals within Europe acquire HCAI 
each year which directly or indirectly results in 147, 000 mortalities [2]. The antimicrobial 
resistance occurs when bacteria develop genetic mutations to protect themselves against 
conventional antibiotics. The overuse and/or inappropriate usage of antibiotics has been 
suggested as the main reason for antimicrobial resistance development in bacteria [155].  
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The global concern about antimicrobial resistance has triggered the development of new 
multi-functional antimicrobial agents. A promising method is the use of novel nanomaterials 
against bacteria in a rapid way so that these bacteria may not be able to develop resistance. The 
nanoparticles (NPs) possess enhanced physicochemical properties compared with their bulk 
counterparts owing to a high surface-to-volume ratio [156]. Metal oxide NPs such as titanium 
oxide (TiO2), zinc oxide (ZnO), selenium oxide (SnO2) and cerium oxide (CeO2) NPs have 
been reported to be effective antimicrobial agents when they are exposed to ultra-violet (UV) 
light [6, 157-160]. Among metal oxide NPs, ZnO NPs with different morphologies and crystal 
structures have been examined for their antimicrobial properties due to attractive features such 
as low cost, ease of synthesis, high photocatalytic activities and good biocompatibility [6].  
The antimicrobial mechanisms vary among different types of NPs. Although the exact 
antimicrobial mechanism of ZnO NP remains unclear, several bacteria-killing pathways have 
been proposed. The toxicity of Zn2+ ion originating from the dissolution of ZnO NPs, reactive 
oxygen species (ROS) generated from the photocatalytic process, and bacterial membrane 
dysfunction have been reported as possible antimicrobial mechanisms for the ZnO-based 
NPs [60, 161-167]. Based upon these pathways, the antimicrobial efficacy of ZnO NPs would 
be strongly dependent on their physical properties such as size, morphology and surface 
energy [6]. Among these properties, the morphology of ZnO NPs may be manipulated by 
synthesis techniques, such as solvothermal, precipitation and sol-gel methods. The details of 
different synthesis methods and the resulting morphologies for ZnO NPs have been reviewed 
by Kolodziejczak-Radzimsk et al. [168] and Sirelkhatim et al. [6].. ZnO NPs in a pure form 
have been demonstrated to be less effective in antimicrobial efficacy, mainly due to their wide 
band-gap and a high recombination rate of charge carriers which result in limited efficiency 
under solar irradiation [162, 169, 170]. The photocatalytic activity of ZnO NPs can be improved 
by modification of their crystal structure via insertion of defects and impurities. Doping of ZnO 
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NPs with other elements such as B, Mn, Mo, Ce, Cu, Pd has been explored as an effective 
strategy in improving the antimicrobial properties of ZnO NPs in the visible light regime [170-
174]. In this study, ZnO-based NPs were synthesised using a solvothermal method. Iodine (I) 
and silver (Ag) were used as single and double dopants with different combinations (I-ZnO, 
Ag-ZnO, I-Ag-ZnO, and Ag-I-ZnO) in order to improve the antimicrobial properties of ZnO 
NPs. The synthesised NPs were then characterized with a range of techniques including X-ray 
diffraction (XRD), X-ray photoelectron spectroscopy (XPS), UV-Vis spectrometry, 
photoluminescence (PL), transmission electron microscopy (TEM) and scanning electron 
microscopy (SEM). The antimicrobial efficacy of the synthesised NPs was investigated against 
Gram-negative Escherichia (E.) coli (MG1655) and Gram-positive Staphylococcus (S.) aureus 
(USA300) bacteria as model microorganisms. 
4.2 Experimental 
4.2.1 Raw material  
The zinc acetate dihydrate (Zn(Ch3COO)2.2H2O, purity > 98 %), ethylene glycol (C2H6O, 
99.8 %), hydriodic acid (HI, 57 wt. % in H2O, 99.95 % HI) and cetyltrimethylammonium 
bromide (CTAB, 99 %) were supplied from Sigma-Aldrich. The zinc nitrate hexahydrate 
(Zn(NO3)2.6H2O, 99.5 %), sodium hydroxide (NaOH, 97 %) and silver nitrate (99.99 %) were 
purchased from Chem-supply. All reagents were of analytical grade and used as received. 
4.2.2 Synthesis and processing  
ZnO NPs were synthesised via the solvothermal method using zinc acetate dihydrate as a 
precursor and ethylene glycol as the solvent. In a typical synthesis, 5.6 g of zinc acetate 
dihydrate was dissolved in 50 ml pure ethylene glycol and the mixture was vigorously stirred 
at 60 °C for 45 min. The mixture solution was then added to a Teflon-lined autoclave to react 
at 170 °C for 18 h. Upon completion of the synthesis, the precipitated ZnO NPs were collected 
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by centrifugation, washed with ethanol and deionized water several times and then dried at 
80 °C for 12 h. The synthesised ZnO NPs were used later as a precursor for I:ZnO NPs. 
The Ag:ZnO NPs were synthesised via the following procedure. In a typical process, 5.6 g zinc 
nitrate hexahydrate, 0.637 g silver nitrate, 0.309 g CTAB and 40 ml of absolute ethanol were 
mixed in a flask. The mixture was vigorously agitated at room temperature for 15 min and then 
0.6 g sodium hydroxide was gradually added. The mixture was stirred for 1 h. The mixture 
solution was then added to a Teflon-lined autoclave to react at 120 °C for 3 h. The precipitated 
silver doped zinc oxide NPs were collected by centrifugation, washed with ethanol and 
deionized water several times and then dried at 80 °C for 12 h.  
The I:ZnO NPs were synthesised by mixing 25 ml of absolute ethanol with hydriodic acid (HI) 
and previously synthesised ZnO NPs at a molar ratio of HI to ZnO of 1:1. The mixture was 
vigorously stirred at room temperature for 4 h and then added to a Teflon-lined autoclave to 
react at 160 °C for 12 h. The I:Ag:ZnO NPs were synthesised from the similar procedure, but 
Ag:ZnO NPs were served as a precursor. The Ag:I:ZnO NPs were also synthesised by doping 
the I:ZnO NPs (as a precursor) with Ag using the above procedure.  
4.2.3 Characterization of as-prepared NPs  
The crystal structure of the synthesised NP samples was analysed by X-ray diffraction (XRD) 
on MiniFlex 600 (Rigaku, Cu Kα, λ = 0.15418 nm). The XRD was operated at 40 kV and 15 mA 
and the X-ray diffractions were collected at the scanning range from 10° to 80° with a step size 
of 0.02°. X-ray photoelectron spectroscopy (XPS) was employed to investigate the surface 
chemistry of the NPs using ESCALAB250Xi (Thermo Scientific, UK). Al kα radiation (photon 
energy, hν = 1486.68 eV) was used as the excitation source. The high resolution (HR) scans 
with a pass energy of 100 eV were carried out. The spectrometer calibration was performed 
using binding energy levels of Cu2p3 (932.62 eV), Ag3d5 (368.21 eV) and Au4f7 (83.96 eV). 
50 
 
The particle size and morphology of synthesised NPs were investigated by a scanning electron 
microscopy (SEM, Quanta 450) and transmission electron microscopy (TEM) FEI Tecnai G2 
Spirit TEM operated at 120 kV accelerating voltage. The hydrodynamic size and zeta potential 
of the synthesized NPs in aqueous suspensions (Milli Q water) were evaluated by dynamic light 
scattering (DLS) using Zetasizer Nano (Malvern Instruments Ltd., UK). A He-Ne laser with a 
wavelength λ = 633 nm was used as the light source.  The intensity of light was scattered at 
173° angle. The optical property of the NPs was evaluated by a spectrophotometer UV-3600 
Plus, Shimadzu with an integrated sphere and a Renishaw inVia Raman Microscope integrated 
with Photoluminescence at an excitation wavelength of 325 nm. The band gap energy of the 
synthesised NPs was calculated by the Tauc plot using the following equation: 
(hνα)1/n = A (hν-Eg), where h is Planck’s constant, ν is the frequency of vibration, α is the 
absorption coefficient, Eg is the band gap, A is a proportion constant and n is  the nature of 
sample transition (n = 2 for indirect allowed transition) [169, 175, 176].  
4.2.4 Antimicrobial evaluation of NPs 
The antimicrobial efficacy of NPs samples was determined in two modes: illumination by 
exposure to visible light and no illumination under the dark conditions. The dark conditions 
were used as a control to evaluate the potential bacterial reduction due to the light source which 
was used to activate ZnO NPs. The antimicrobial efficacy results in dark conditions also assist 
in elucidating the mechanism(s) other than ROS of the as-synthesized ZnO NPs. The NP 
concentration of 1 mg/ml in PBS was applied in all antimicrobial evaluation experiments. Five 
NP samples of ZnO, I:ZnO, Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO were used. Bacterial growth 
without any NPs was used as the control for bacterial behaviour under illumination and dark 
conditions. The antimicrobial properties of NPs were assessed against both the Gram-negative 
bacterium E. coli MG1655 and the Gram-positive bacterium S. aureus USA300. Cells were 
grown to the mid-logarithmic phase in Mueller Hinton Cation Adjusted media (Becton 
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Dickinson), and diluted in phosphate buffered saline (PBS) solution to obtain105 colony 
forming units per ml (CFU/ml) in each assay.  
Each antimicrobial test was performed inside a sterilized 4 ml glass vial. The glass vial was 
selected due to its light transparency of the glass materials. A LED light source (U9090 LED) 
with a peak wavelength at 420 nm and a radiant flux of 6,500 mW was used for the illumination 
mode in a distance of about 10 cm from bacterial growth samples inside the shaker incubator. 
For the dark conditions, the vials were placed in 50 ml tubes with a black colour. The 
experiments were performed simultaneously in separate incubators under illumination and dark 
conditions. Shaking was performed to prevent sedimentation of the NPs. Each assay included 
950 μL of normalised bacteria with the viable cell number of 105 CFU/ml with 50 μL of a 
specific NP sample. The vials were mixed by a vortex mixer and then placed into a shaker at 
37 °C for 1 h under either an illumination or a dark condition. Upon completion of the treatment, 
samples were spread on Luria Bertani 1.5 % agar plates for bacterial enumeration and the 
determination of the antimicrobial efficacy in that test. Each sample was assessed in triplicate. 
Statistical analysis was performed using a one-way ANOVA, with a statistical significance 
indicated by ns for P>0.05; * for P <0.05; ** for P <0.01; *** for P <0.001; and **** for P 
<0.0001, respectively. 
4.3 Results and discussion 
4.3.1 XRD 
XRD is an analytical technique to characterize the crystalline material and evaluate the crystal 
structure, crystal orientation and crystal defects. The XRD patterns for the synthesised NP 
samples are presented in Figure 1.  The XRD pattern for the ZnO NPs confirms the sample is 
crystalline in nature. The diffraction peaks for ZnO NPs are located at 32°, 34°, 36°, 47°, 56°, 
63°, 66°, 68° and 69° which correspond to the ZnO wurtzite structure indexed with (100), (002), 
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(101), (102), (110), (103), (200), (112) and (201), respectively. The indices of ZnO NP are in 
agreement with those in the ZnO standard powder diffraction file (PDF) code number: 00-036-
1451 that has been referenced in several studies [154, 177, 178]. The XRD patterns for I:ZnO 
and Ag:ZnO NPs samples are similar to those of the ZnO NP sample without any distinctive 
peaks for I and Ag species or any significant shift in the location of the diffraction peaks. This 
indicates that the lattice structure of the ZnO NP crystal has not significantly changed, which 
may be due to a low concentration of dopants used in the synthesis. Both Ag and I dopant 
concentrations may also be below the detection limits of the XRD equipment for I:ZnO and 
Ag:ZnO NP samples [96]. The XRD of the I:Ag:ZnO and Ag:I:ZnO NP samples present a 
similar pattern as the ZnO sample but they have additional peaks at 30°, 38° and 44°. The 
additional peaks are partially assigned to Ag and AgI using the PDF card numbers 5000218 and 
9011698, respectively.  
The XRD peaks confirm the presence of Ag and I elements within the crystal structure of 
synthesised ZnO-based NPs (I:Ag:ZnO; Ag:I:ZnO). Modification of the crystal structure of 
ZnO-based NPs may improve the photocatalytic activities of ZnO NPs and potentially lead to 
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generation of ROS in the visible light region.  
 
Figure 1 XRD patterns of ZnO, I:ZnO, Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO NP samples 
4.3.2 XPS 
Apart from XRD, we also employed XPS as a tool to evaluate the elemental compositions, 
concentrations and chemical bindings of the synthesized NPs. The XPS spectra for the 
I:Ag:ZnO NP sample is presented in Figure 2, while the spectra for ZnO, I:ZnO, Ag:ZnO and 
Ag:I:ZnO NP samples are provided in Supplementary Information (SI).  
The XPS survey spectra confirm the presence of Zn, O, Ag and I elements in both I:Ag:ZnO 
and Ag:I:ZnO synthesised NP samples. The binding energy peaks for Zn 2p 3/2 and 2p 1/2 are 
found at 1,022 and 1,045 eV, respectively, for all five samples (Fig 2b, S.F.1-4b). The 
well-defined peak at 1,022 eV for the binding energy is accurately assigned to the ZnO 
compound [179]. Three peaks at 530 eV, 531 eV and 532 eV appear in the spectrum for O 1s 
(Fig 2c, S.F.1-4c), indicating different oxygen species in the samples. The binding energy at 
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530 eV is assigned to the oxygen-zinc bonding for ZnO and I:ZnO NP samples, while the peak 
is assigned to the oxygen-silver bonding for  Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO NP samples. 
The other two peaks of 531 eV and 532 eV are associated with the oxygen-zinc bonding for all 
five NP samples. The Ag 3d binding energy spectrum for Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO 
NP samples has two peaks at 367 eV and 373 eV (Fig 2d, S.F.3-4d). The first peak at 367 eV 
is due to the silver-oxygen bonding. The I 3d binding energy spectrum for I:ZnO, I:Ag:ZnO 
and Ag:I:ZnO NP samples holds two peaks at 619 eV and 630 eV (Fig 2e, S.F.2d, S.F.4e). The 
619 eV peak corresponds to the iodine-iodine bonding.  
The XPS spectra for the I:Ag:ZnO and Ag:I:ZnO NP samples (Fig 2 b-e and S.F.4 b-e) show a 
similar spectral pattern of the binding energies for Zn 2p3, O 1s, Ag 3d and I 3d, indicating the 
presence of the ZnO NPs, Ag and I elements in these two NP samples. 
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Figure 2 XPS spectra, I:Ag:ZnO XPS survey (a), I:Ag:ZnO XPS spectra (b-e). The binding 
energy spectra for Zn 2P3 (b), binding energy spectra for O 1s (c), binding energy spectra for 
Ag 3d (d) and binding energy spectra for I 3d (e). 
56 
 
4.3.3 Morphology 
The morphology of the ZnO NPs synthesised via the solvothermal method could be controlled 
by different parameters including the type of precursors, solvents and surfactants employed for 
the synthesis as well as the processing conditions such as temperature and the reaction 
time [168]. The morphology of the synthesised NPs was investigated by TEM and SEM 
analysis and is presented in Figures 3 and 4. In addition, the hydrodynamic size and zeta 
potential for the synthesised NPs were evaluated and presented in Table 1. The TEM images 
confirm a polycrystalline structure with a main shape of hexagonal prisms for all NPs. However, 
the Ag:ZnO sample (Fig 3c) presents a distorted crystal form. The images also reveal 
aggregation of the NPs from uniform-sized discrete particles with an average particle size 
between 32 nm to 92 nm.  
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Figure 3 TEM images of ZnO (a), I:ZnO (b), Ag:ZnO (c), I:Ag:ZnO (d) and Ag:I:ZnO (e) 
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A quasi-spherical morphology is observed from the SEM images of four synthesised NPs (ZnO, 
I:ZnO, Ag:ZnO, and Ag:I:ZnO) in Figure 4, while a flaky shape is noticed for the I:Ag:ZnO 
NP sample. The SEM images confirm the aggregation of NPs for all samples.  
 
Figure 4 SEM images of ZnO (a), I:ZnO (b), Ag:ZnO (c), I:Ag:ZnO (d) and Ag:I:ZnO (e) 
The DLS technique estimates the particle size based on light scattering and the Brownian 
motion of particles in a solution medium. The DLS results suggest the tendency of the 
59 
 
synthesized NPs for agglomeration/aggregation in an aqueous solution for all five samples as 
the estimated mean hydrodynamic particle sizes are much higher than TEM measurements.  The 
insertion of Ag into the ZnO NPs (Ag: ZnO) does not have an impact on the size, however 
Ag:I:ZnO NP size increases after Ag insertion into I:ZnO NPs. The I insertion (I:ZnO) leads to 
doubling the size of ZnO NPs, and this doubling in size also applies to I insertion into Ag:ZnO 
NPs(I:Ag:ZnO).  
The Zeta potential results reveal a good stability (zeta potential > + 30 mV or < - 30 mV) for 
the synthesized NPs apart from I:ZnO NPs. The ZnO and Ag:ZnO NP samples display a 
positive value for the zeta potential while the I:ZnO, I:Ag:ZnO and Ag:I:ZnO NPs samples 
show a negative zeta potential. The zeta potential of NPs could be influenced by the precursors 
used for the synthesis, surfactant and more importantly by pH [180].  The surface charge of 
NPs may impact their toxicity toward bacteria. The NPs with a stable positive charge may 
interact better with the bacteria which has a slightly negative charge. However, the surface 
charge interaction is not considered to be a major factor in the antimicrobial effectiveness of 
NPs. 
Table 3 Dynamic light scattering and zeta potential measurements for the synthesised 
nanoparticles 
Samples  DLS size (nm) Zeta Potential (mV) 
ZnO 131.8 + 9.7 +32.9 + 11 
I:ZnO 236.3 + 40.6 -9.2 + 4.4 
Ag:ZnO 144.5 + 23.5 +47.3 + 5.5 
I:Ag:ZnO 274.9 + 20.1 -23.3 + 6.6 
Ag:I:ZnO 326.2 + 50.4 -38.5 + 6.8 
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4.3.4 UV-Vis spectroscopy 
The UV-Vis diffuse spectra and the corresponding Tauc plot of the synthesised NP samples are 
shown in Figure 5. The absorption peak at a wavelength less than 400 nm for all synthesised 
NP samples suggests strong light absorbance of the NP samples in the UV region and the 
presence of well crystalline ZnO NPs in the samples [181, 182]. The peak at 380 nm is assigned 
to excitation in ZnO NPs which is due to the electron transition from the valence to the 
conduction band upon excitation [181, 183, 184]. By comparing the UV-Vis spectra for the 
I:Ag:ZnO and Ag:I:ZnO NP samples with those of ZnO NP samples, enhancement in the optical 
absorption is found for both I:Ag:ZnO and Ag:I:ZnO NP samples. The absorption peaks at 426 
nm and 433 nm are detected for I:Ag:ZnO and Ag:I:ZnO NP samples respectively, which may 
be due to the plasma effect of Ag [185]. The band gap for the synthesised NP samples was 
calculated from the intercept of the tangent of the curves from the Tauc plot as shown in the 
inset of Figure 5. The band gap energy for the I:Ag:ZnO and Ag:I:ZnO NP samples are found 
to be 2.28 eV and 3.21 eV, respectively. The Ag:I:ZnO NP sample has a weak peak at around 
2.9 eV. The band gap energies for both samples are in agreement with the UV-Vis spectra, 
indicating that photocatalytic activity of ZnO NPs has been improved by double doping with I 
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and Ag in two different dopant configurations. 
 
Figure 5 UV-Vis spectra for ZnO, I:ZnO, Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO NP samples. The 
inset represents the Tauc graphs for the synthesised NP samples. 
4.3.5 Photoluminescence (PL) 
The PL spectrum reveals the interaction of the NP material with photons after exposure to UV 
light and provides great insights into the efficiency of the charge carrier. The energy absorption 
by the NPs leads to light emissions which are interpreted as peaks in the PL graph. This 
absorption of a photon (excitation) occurs either by the lattice of the NP or the intentionally 
doped material. As mentioned before, the absorption of photons in ZnO-based NPs leads to the 
generation of ROS and hence improves antimicrobial properties. Therefore, PL peaks in the 
visible light region could be positively correlated with the antimicrobial activity of NPs in the 
visible light region. 
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Figure 6 below presents the PL spectra of the synthesised NP samples. The ZnO NP sample has 
a sharp peak at 390 nm and then the PL spectrum becomes flatten in the visible light range 
between 400 to 700 nm. Other samples also reveal a strong peak at the wavelength of less than 
400 nm except for the Ag:ZnO sample from which only a soft peak at 600 nm is detected. 
Among these five samples tested, I:ZnO has a sharp peak at 388 nm and a broad peak in the 
visible light range. The PL spectra for the I:Ag:ZnO and Ag:I:ZnO samples are presented in the 
inset of Figure 6 for better clarity of peak locations. Peaks are seen from both samples in the 
visible light range. The I:Ag:ZnO NP sample has a broad peak between 470 and 700 nm with 
a low intensity, while two peaks from Ag:I:ZnO are seen, one at 458 nm and the second at 529 
nm with a higher intensity.  
 
Figure 6 Photoluminescence spectra for ZnO, I:ZnO, Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO NP 
samples. The inset represents PL spectra for the I:Ag:ZnO and Ag:I:ZnO samples for better 
clarity of peak locations 
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4.3.6 Antimicrobial efficacy 
The antimicrobial efficacy results for the NP samples evaluated against E. coli and S. aureus 
are shown in Figures 7 and 8 respectively. Both microorganisms were treated in visible light 
and under a dark condition in the presence of the NP samples. The results in Figure 7 
demonstrate the Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO NP samples are very effective in killing 
E. coli in the light-illuminated mode, resulting in 5.27 log CFU reduction in survival, while 
only 0.04 and 0.13 log CFU reduction of E. coli in the light-illuminated mode is found for the 
ZnO and I:ZnO NP samples respectively. Among these five NP samples tested against E. coli 
in the dark condition, the Ag:ZnO and Ag:I:ZnO  NP samples outperform other samples with a 
greater antimicrobial activity: 5.26 and 1.01 log CFU reduction in survival, respectively. On 
the contrary, ZnO, I:ZnO and I:Ag:ZnO NP samples are less effective, and only 0.02, 0.05 and 
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0.10 log CFU reduction of bacterial cells are achieved, respectively. 
 
Figure 7 Antimicrobial efficacy of the doped ZnO NPs against E. coli (MG1655). Statistical 
analysis was performed using a one-way ANOVA, with a statistical significance indicated (ns, 
P>0.05; *, P <0.05; **, P <0.01; ***, P <0.001; and **** for P <0.0001) 
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Figure 8 Antimicrobial efficacy of the doped ZnO NPs against S. aureus (USA300). Statistical 
analysis was performed using a one-way ANOVA, with a statistical significance indicated (ns, 
P>0.05; *, P <0.05; **, P <0.01; ***, P <0.001; and ****, P<0.0001) 
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 The antimicrobial efficacy of the NP samples follows a similar pattern against S. aureus. The 
Ag:ZnO, I:Ag:ZnO and I:Ag:ZnO NP samples are very potent in eliminating S. aureus in the 
light-illuminated mode with 100 % reduction in the CFU, while the other two samples have a 
lower efficacy, ZnO with 0.14 log CFU reduction and I:ZnO with 0.03 log CFU reduction of 
bacterial cells after the exposure to visible light. In the dark condition, the Ag:ZnO NP sample 
is still very potent in eliminating S. aureus and has the highest antimicrobial efficacy amongst 
five NP samples. In contrast, ZnO, I:ZnO, I:Ag:ZnO and Ag:I:ZnO NP samples have minor or 
moderate antimicrobial activity, with 0.06, 0.10, 0.14 and 0.24 log CFU reduction of S. aureus, 
respectively.  
The synthesised NPs showed a rapid antimicrobial efficacy in 1 h compared with other studies 
which have used a long exposure time up to 24 h [114, 186]. In this study, the antimicrobial 
efficacy of NPs was based on a quantitative determination by direct contact between NPs and 
bacteria followed by the agar plate counting. Several other studies have used the disc diffusion 
technique which is a qualitative (soft-quantitative) method of antimicrobial efficacy evaluation 
[86, 187].  
The above results for the synthesised NPs confirm that the antimicrobial efficacy of ZnO NPs 
has been significantly enhanced by the doping process. Among all NP samples, ZnO-based NPs 
doped by Ag (Ag: ZnO) surpass other samples in eliminating both E. coli and S. aureus bacteria.  
4.4 Antimicrobial mechanisms by Ag/I doped ZnO NPs 
The antimicrobial mechanisms by ZnO NPs remain debated and these mechanisms include Zn2+ 
release, ROS generation, Ag+ release, and others. We have designed five ZnO NP samples 
under illumination or dark conditions in order to illustrate the mechanisms underlying for 
ZnO NPs.  
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It has been reported that it is the interaction of the Zn2+ ion with the bacterial cell membrane 
that results in disruption of bacterial metabolism and the eventual death of the bacterial cell 
because the Zn2+ ion enters into the bacterial cell and binds with the sulfhydryl, amino and 
hydroxyl functional groups [162, 188, 189]. Alternatively, ZnO NPs with a slightly positive 
charge could attach to the bacterial cell membrane with a slightly negative charge due to 
electrostatic interaction. The direct contact of ZnO NPs could lead to loss of the charge balance 
on the cell membrane, or ruptures the cell member, and ultimately breaks the integrity of the 
cellular structure [154, 162]. However, from our ZnO samples in the dark condition, negligible 
antimicrobial results are found for both E. coli and S. aureus, which suggests that Zn ions or 
positive charge in the ZnO samples do not contribute to the bacterial cell death.  
Another possible mechanism is ROS generated from semiconductor NPs after exposure to 
external light. The photo-generated ROS from ZnO NPs under UV light irradiation has been 
studied for antimicrobial purposes by Talebian et al. [111]. ZnO NPs are a semiconductor with 
a band gap of approximately 3.37 eV [190]. Upon irradiation by UV light, ZnO NPs can 
generate ROS via the photocatalytic process. The ROS have strong antimicrobial toxicity that 
is correlated with their extremely high oxidizing properties. The ZnO NPs absorb the photons 
when they are illuminated with photons with an energy equal to and greater than its band-gap 
(λ < 369 nm). The absorbed photons prompt the electron to be excited from the valence band 
(VB) to the conduction band (CB), which hence leads to the formation of free electrons (e-) in 
CB and holes (h+) in VB. The combination of the free electron-hole (e-/ h+) pair could convert 
the electron-hole pair energy to heat and reduce the photocatalytic activities of the 
semiconductor NPs [75]. In the presence of water, the electron-hole pair simultaneously splits 
the water molecule into a hydroxyl radical (•OH) and a hydrogen ion (H+). The electron-hole 
pair also reacts simultaneously with the dissolved oxygen in  water to form superoxide radicals 
(•O2-) [75, 154, 157]. 
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The hydroxyl radical and the superoxide anion radical are negatively charged and hence cannot 
penetrate into the bacterial cell membrane which has a slightly negative charge [191, 192]. 
Accumulation of the hydroxyl radical, however, results in lipid peroxidation in the bacterial 
outer membrane, and causes detrimental damage to the bacterial cellular structure [157]. The 
H2O2 has been reported to be the main antimicrobial active agent to be responsible for bacterial 
non-viability [6, 154]. We have observed that ZnO samples contribute to a slight reduction in 
both strains after exposure to visible light, which confirms ROS generation is the mechanism 
for cellular death, not Zn ions. However, the level of reduction is very limited because the 
photo-generated ROS from ZnO NPs with a wide band-gap requires activation by exposure of 
NP samples to UV light. The UV light constitutes less than 5 % of the sunlight spectrum, which 
hampers the utilization of pure ZnO NPs for antimicrobial applications [193].  
In general, the band-gap narrowing approach is a common method to shift the photocatalytic 
activity of wide band-gap photocatalytic NPs from UV light to the visible light range. The 
band-gap narrowing process is achieved by reducing the conduction band energy, increasing 
the valence band energy or introducing an intermediate energy level within the band-gap. The 
doping process is often employed for narrowing the band gap of NPs [169, 194]. A carefully 
selected multifunctional dopant could enhance the photocatalytic properties in the visible light 
region for efficient ROS generation also improve the antimicrobial properties of the NP 
compound, due to the inherent antimicrobial activity of the dopant. In general, dopants are 
classified into two categories: n-type and p-type. In n-type doping for ZnO NPs, zinc (Zn) or 
oxygen (O) is substituted with group III elements. The n-type dopants have extra electrons in 
their valence band which can be donated to the adjacent atoms (Zn cation) in the crystal 
structure.  In contrast, the p-type dopants, such as group I elements, lack electrons in their 
valence band, hence, they receive an electron from the neighbouring atoms to generate holes in 
the valence band. Therefore, the donor dopants increase the electron concentration while the 
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acceptor dopants increase the hole concentration. The p-type doping of ZnO NPs is a 
challenging process due to several factors including low solubility, high ionization and the 
formation energy of p-type dopants [194-196].  
In this study, we have selected Ag and I elements in either a single or a double dopant form 
with various arrangements to utilize ZnO-based NPs in the visible light region for antimicrobial 
applications. Iodine has selected as it has been evaluated as a strong dopant to improve the 
photocatalytic properties of TiO2 NPs by modifying the band-gap and reducing the electron-
hole pair recombination by trapping the photogenerated electron [96].  Ag has been reported to 
be effective as an electron trap for delaying the recombination of the electron-hole pair, hence, 
the Ag dopant can improve the photocatalytic properties of the NP-based semiconductor [197]. 
Comparison of the antimicrobial efficacy for I:ZnO, Ag:ZnO, I:Ag:ZnO and Ag:I:ZnO samples 
against E. coli and S. aureus in both light-illuminated and dark conditions suggests that ROS 
generation be one antimicrobial mechanism for these NPs. Significant reduction in the CFU of 
both strains is observed for the I:Ag:ZnO sample after exposure to light in comparison with the 
dark condition. Although there is no contribution from I:ZnO to S. aureus cell death, a slight 
reduction in E. coli cell survival is noticed from this sample after exposure to visible light. ROS 
contribution from Ag:ZnO and Ag:I:ZnO samples to eliminating E.coli cells may not be 
interpreted from our experiments since in both illuminated and dark conditions, the sample 
destroys all or most of this type of cells. We do notice that ROS generation from both samples, 
especially Ag:I:ZnO, explains the further reduction in S. aureus cell survival after exposure to 
visible light. This ROS generation capability and thus the antimicrobial activity of these 
samples may be well correlated with their photocatalytic activity as shown in Figure 6. 
We observe that Ag:ZnO and Ag:I:ZnO samples are able to eliminate most of E. coli cells, 
while some of  S. aureus cells. This is due to the silver ion (Ag+) released from the dissolution 
of the metallic silver that has been suggested as an antimicrobial mechanism for Ag related 
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products. Upon interaction of Ag with the water molecules, the dissolved oxygen (O2) in the 
water oxidizes Ag to form Ag+ which is an active antimicrobial ingredient [44, 56, 68, 132]. 
The Ag+ ions can cause the bactericidal efficacy by binding them with thiol, sulfur and 
phosphorus groups of the bacterial cell wall to produce holes on the bacterial cell wall. The 
holes on the cell wall allow the Ag+ ions to enter the bacterial cell and bind with DNA which 
leads to cell death [56, 57, 150-152, 198]. The Gram-negative bacteria have been suggested to 
be more susceptible toward Ag+ ions due to their thinner cell membrane and a more negative 
charge due to their surface lipopolysaccharide (LPS) layer. The favourable electrostatic 
interactions could lead to the interaction between Ag+ ions and the cell outer membrane, 
penetration of the membrane and subsequent death of bacterial cells [5, 154]. However, the use 
of pure silver as an antimicrobial agent is limited due to high cost and uncontrolled release of 
the Ag+ ions, which could also result in localised toxicity to human cells [24]. From our doped 
ZnO samples, the Ag:ZnO and Ag:I:ZnO samples are very potent against E. coli in both 
light-illuminated mode and dark conditions, which means Ag+ do contribute to the 
antimicrobial mechanism. Ag+ penetration is better for Gram-negative bacteria than 
Gram-positive bacteria as evidenced by a relatively higher percentage of S. aureus CFUs in the 
dark condition. Silver in the form of AgO is present in the Ag:ZnO and Ag:I:ZnO samples, 
which has been confirmed through XPS spectra shown in Fig S.F.3-4. This ionic form is 
released upon contact with bacterial cells. However, I:Ag:ZnO is not effective as Ag:I:ZnO in 
the dark condition for both strains, and this may be due to the formation of AgI, rather than 
AgO, in the sample. The Ag+ release rate from AgI may be much slower than that from AgO. 
Furthermore, Ag concentration is very low in the doping process and it is not detectable for 
XRD spectra as shown in Figure 1 for Ag:ZnO samples, however, such a small fraction of Ag 
in the sample makes a great contribution to the elimination of bacterial cells.  
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4.5 Conclusions 
ZnO-based NPs doped with I and Ag with different doping sequences were synthesised. The 
XRD characterization of synthesised NPs confirms a crystalline structure for ZnO NPs and the 
presence of Ag and I dopants in different arrangements. The XPS analysis reveals the chemical 
binding and elemental compositions, hence shedding light on the forming process of ZnO-based 
NPs with the selected dopants. The UV-Vis and PL analysis provide direct evidence of the 
photocatalytic enhancement in double-doped ZnO NPs (I:Ag:ZnO and Ag:I:ZnO) compared 
with ZnO NPs in the visible light region. The SEM and TEM analysis of the synthesised NPs 
further reveals a polycrystalline structure consisting of hexagonal prisms for all NPs with an 
average particle size between 32 nm to 92 nm. I:Ag:ZnO and Ag:I:ZnO NP samples 
demonstrate a strong antimicrobial efficacy against E. coli and S. aureus in the visible light 
region with different dominant mechanisms: ROS generation for the I:Ag:ZnO sample, while 
Ag+ release for the Ag:I:ZnO sample. A very low Ag concentration in the format of AgO for 
Ag-related products may be enough for completely eliminating pathogenic bacteria.  
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Chapter 5 :        Conclusions and future directions 
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The nosocomial bacterial infections are a major cause of mortality mainly because overuse 
and/or inappropriate usage of antibiotic agents leads to the development of antimicrobial 
resistant bacteria. The antimicrobial resistance is less likely to occur for nanomaterials due to 
their nature and mechanism of fighting against bacteria. In this study, two strategies were 
evaluated for the antimicrobial applications including nanostructured coatings and 
nanoparticles.  
In the first study, magnetron sputtering was used to produce a very thin Cr-Ag coating. The 
results of the nanoindentation measurements exhibit acceptable mechanical properties for the 
coatings. The study confirms the antimicrobial properties of Cr-Ag coatings can be tuned by 
varying the Ag content. However, in contrary to expectations, the 15.23 % Ag coating did not 
have a greater antimicrobial efficacy than the 4.83 % Ag coating against either 
Escherichia coli (MG1655) or Staphylococcus aureus (USA300). Several hypotheses have 
been proposed, but more samples of Cr-Ag coatings with different Ag concentratons are 
required in order to validate these hypotheses. A further investigation into the mechanism of 
antimicrobial action and the relationship with the concentration of silver in the Cr-Ag coating 
needs to be studied in future. Also, evaluating different elements such as tungsten (W) or copper 
(Cu) with various concentrations may assist in producing more efficient coatings.   
In the second study, ZnO-based nanoparticles were synthesized via a Solvothermal method. 
Iodine and silver were used as a single and double dopants with different combinations (I-ZnO, 
Ag-ZnO, I-Ag-ZnO, and Ag-I-ZnO) in order to improve the antimicrobial properties of ZnO 
NPs and study the antimicrobial mechanism of ZnO nanoparticles derivatives under visible 
light. The characterization tests on the synthesised samples have confirmed the improved 
photocatalytic activity of double doped ZnO NPs with I:Ag:ZnO and Ag:I:ZnO arrangement 
compared with ZnO NPs. The synthesised I:Ag:ZnO and  Ag:I:ZnO NPs had demonstrated 
their potent efficacy against Escherichia coli (MG1655) and Staphylococcus aureus(USA300) 
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and they may have great potential application in combating infectious diseases. More 
importantly, the mechanisms underlying the antimicrobial samples were revealed: synergistic 
effect of reactive oxygen species (ROS) generation and Ag+ release. However, ROS generation 
was more dominant in the I:Ag:ZnO sample, while Ag+ release played an important role in the 
Ag:I:ZnO. We also confirmed that a small fraction of Ag in the AgO form in the sample was 
enough to eliminate these pathogenic bacteria. 
The future study will be focussed on synthesis and optimization of novel semiconductor based 
(e.g. ZnO, TiO2, etc) NPs with different dopants suitable for specific biomedical applications. 
The antimicrobial mechanisms of action and biocompatibility of as-synthesized NPs will be 
investigated more in depth. The optimizations may include evaluation of different surfactants, 
annealing at various temperatures and the other NP synthesis methods.  
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Figure S.F.1 - XPS spectra, ZnO XPS survey (a), ZnO XPS spectra (b-c) 
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Figure S.F.2 - XPS spectra, I:ZnO XPS survey (a), I:ZnO XPS spectra (b-d) 
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Figure S.F.3 - XPS spectra, Ag:ZnO XPS survey (a), Ag:ZnO XPS spectra (b-d) 
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Figure 4 S.F.4 - XPS spectra, Ag:I:ZnO XPS survey (a), Ag:I:ZnO XPS spectra (b-e). The 
binding energy spectra for Zn 2P3 (b), binding energy spectra for O 1s (c), binding energy 
spectra for Ag 3d (d) and binding energy spectra for I 3d (e). 
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